ReachMD

Be part of the knowledge.™

Women's Health

441

LikeLikedUnlike

Episodes 1-15 of 36

Case of the Patient in Midlife: Weighing Potential Changes in ASCCP Guidelines
CME/CE
Case of the Patient in Midlife: Weighing Potential Changes in ASCCP Guidelines
- Warner K. Huh, MD
  Peer
- Sarah E. Dilley, MD, MPH, FACOG
  Peer
0.25 credits
Assessing and Addressing ID/IDA: The Need for Guidance
MinuteCE®
Assessing and Addressing ID/IDA: The Need for Guidance
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Arjeme Denise Cavens, MD
  Peer
1.00 program credits
All Oral Iron Therapies Are Not Created Equal
MinuteCE®
All Oral Iron Therapies Are Not Created Equal
- Arjeme Denise Cavens, MD
  Peer
- Lee Shulman MD, FACOG, FACMG
  Peer
1.00 program credits
Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding
MinuteCE®
Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Arjeme Denise Cavens, MD
  Peer
1.00 program credits
“In Any Case?” The Importance of Iron Repletion
MinuteCE®
“In Any Case?” The Importance of Iron Repletion
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Arjeme Denise Cavens, MD
  Peer
1.00 program credits
Iron Supplementation Formulations for Females with ID/IDA: Monitoring Response
MinuteCE®
Iron Supplementation Formulations for Females with ID/IDA: Monitoring Response
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Michael Auerbach, MD
  Peer
1.00 program credits
How a Woman’s Iron Status Today Can Impact a Baby’s Health Tomorrow – and Through the Years
MinuteCE®
How a Woman’s Iron Status Today Can Impact a Baby’s Health Tomorrow – and Through the Years
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Michael K. Georgieff, MD
  Peer
1.00 program credits
The Impact and Importance of Iron Status
MinuteCE®
The Impact and Importance of Iron Status
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Michael Auerbach, MD
  Peer
1.00 program credits
Strategies to Effectively Manage ID and IDA Throughout the Life Span
MinuteCE®
Strategies to Effectively Manage ID and IDA Throughout the Life Span
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP
  Peer
1.00 program credits
ID and IDA in Postmenopausal Women
MinuteCE®
ID and IDA in Postmenopausal Women
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Michael Auerbach, MD
  Peer
1.00 program credits
Enhancing Adherence with Oral Iron Therapy
MinuteCE®
Enhancing Adherence with Oral Iron Therapy
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP
  Peer
1.00 program credits
Contributors to Iron Status: Serum Ferritin, TSAT, and Hemoglobin
MinuteCE®
Contributors to Iron Status: Serum Ferritin, TSAT, and Hemoglobin
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Michael Auerbach, MD
  Peer
1.00 program credits
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
CME/CE
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
- Lee P. Shulman, MD, FACMG, FACOG
  Peer
- Roberto Romero, MD, DMedSci
  Peer
0.25 credits
MinuteCE®
Iron Deficiency and Iron Deficiency Anemia in Your Female Patients: Who Is at Risk, How to Diagnose, How to Manage
- Malcolm G. Munro MD, FRCS(c), FACOG
  Peer
- Michael Auerbach, MD
  Peer
- Michael K. Georgieff, MD
  Peer
- Wendy Wright, DNP, FNP-BC, ANP-BC, FAANP, FAAN, FNAP
  Peer
- Arjeme Denise Cavens, MD
  Peer
- Lee Shulman MD, FACOG, FACMG
  Peer
1.00 credits 11 episodes
The Oncogenic Significance – and Promise – of HER3 in Pharmacotherapy
CME/CE
The Oncogenic Significance – and Promise – of HER3 in Pharmacotherapy
- Helena Yu, MD
  Peer
- Makenzi Evangelist, MD
  Peer
0.50 credits

Program Chapters

Segment Chapters

Playlist:

Recommended